Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · IEX Real-Time Price · USD
0.535
-0.027 (-4.74%)
Jun 20, 2024, 2:17 PM EDT - Market open

Ensysce Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2017
Net Income
-10.63-25.09-29.890.06-10.1
Upgrade
Depreciation & Amortization
00000
Upgrade
Share-Based Compensation
0.881.070.120.186.04
Upgrade
Other Operating Activities
-1.055.2120.72-1.483.13
Upgrade
Operating Cash Flow
-10.78-17.89-8.24-1.25-0.94
Upgrade
Capital Expenditures
00000
Upgrade
Investing Cash Flow
00000
Upgrade
Share Issuance / Repurchase
9.053.786.8900
Upgrade
Debt Issued / Paid
0.155.5313.421.10.5
Upgrade
Other Financing Activities
-0.45-0.55-0-
Upgrade
Financing Cash Flow
8.768.7720.311.10.5
Upgrade
Net Cash Flow
-2.02-9.1212.07-0.15-0.44
Upgrade
Free Cash Flow
-10.78-17.88-8.24-1.25-0.94
Upgrade
Free Cash Flow Per Share
-4.76-99.39-98.10-18.98-9.02
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).